Rothschild healthcare exit may reach 10x

The Paris-based firm, which invested $10m in Vessix Vascular in June 2011, has exited the business, generating an initial 3.5x return multiple that could increase up to 10x in the next three years.

17 January 2013•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail